Levosimendan in Patients With Impaired Right Ventricular Function Undergoing Cardiac Surgery
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Perioperative right ventricular (RV) function is an important determinant of postoperative
outcomes after cardiac surgery. Perioperative RV dysfunction increases the need for
perioperative inotropic support, prolongs intensive care unit stay and increases in-hospital
mortality, in this study, we aim to investigate the effect of the preoperative administration
of levosimendan on the outcome of patients with compromised right ventricular function
undergoing cardiac surgery